- Home
- VALU vs RXST Comparison
VALU vs RXST Comparison
Compare VALU & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- RXST
- Stock Information
- Founded
- VALU 1931
- RXST 1997
- Country
- VALU United States
- RXST United States
- Employees
- VALU N/A
- RXST N/A
- Industry
- VALU Investment Managers
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VALU Finance
- RXST Health Care
- Exchange
- VALU Nasdaq
- RXST Nasdaq
- Market Cap
- VALU 345.7M
- RXST 352.3M
- IPO Year
- VALU N/A
- RXST 2021
- Fundamental
- Price
- VALU $37.90
- RXST $8.55
- Analyst Decision
- VALU
- RXST Hold
- Analyst Count
- VALU 0
- RXST 11
- Target Price
- VALU N/A
- RXST $11.80
- AVG Volume (30 Days)
- VALU 5.3K
- RXST 1.2M
- Earning Date
- VALU 09-12-2025
- RXST 08-07-2025
- Dividend Yield
- VALU 3.36%
- RXST N/A
- EPS Growth
- VALU 8.91
- RXST N/A
- EPS
- VALU 2.20
- RXST N/A
- Revenue
- VALU $35,079,000.00
- RXST $147,059,000.00
- Revenue This Year
- VALU N/A
- RXST N/A
- Revenue Next Year
- VALU N/A
- RXST $6.71
- P/E Ratio
- VALU $17.66
- RXST N/A
- Revenue Growth
- VALU N/A
- RXST 27.68
- 52 Week Low
- VALU $32.94
- RXST $6.32
- 52 Week High
- VALU $57.68
- RXST $57.53
- Technical
- Relative Strength Index (RSI)
- VALU 48.80
- RXST 49.54
- Support Level
- VALU $37.11
- RXST $8.37
- Resistance Level
- VALU $38.85
- RXST $9.37
- Average True Range (ATR)
- VALU 1.03
- RXST 0.60
- MACD
- VALU 0.01
- RXST 0.21
- Stochastic Oscillator
- VALU 58.46
- RXST 70.18
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.